Global Diverticular Treatment Market
Global Diverticular Treatment Market

Diverticular Treatment Comprehensive Study by Type (Antibiotics Treatment, Symptomatic Treatment), Application (Diverticulosis, Diverticulitis), Indication (Symptomatic Uncomplicated Diverticular Disease, Recurrent Symptomatic Diverticular Disease, Complicated Diverticular Disease), Distribution Channel (Hospital Pharmacy, Retail Pharmacies, Drug Stores, Online Pharmacy, Others), Diagnosis (CT Scan, Ultrasound, Urine Test, Blood Test) Players and Region - Global Market Outlook to 2026

Diverticular Treatment Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

May 2021 Edition 249 Pages 217 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Diverticular Treatment Market Overview:
Diverticular disease is a digestive disorder that causes sacs or small bulges to develop in the large intestine wall. These sacs can develop in any part of the colon, but they are most common in the sigmoid colon. Diverticular disease is caused by a variety of factors including a low-fiber diet, lack of physical activity, and some medications such as anti-inflammatory drugs, vitamin D deficiency, obesity, and smoking. The growing prevalence and recurrence of diverticular disease is expected to be the major factor driving the growth of the diverticular disease therapeutics market over the forecast period.

Growth Drivers
  • Growing Prevalence and Recurrence of Diverticular Disease
  • Rise in Cigarette Smoking Population

Market Trends
  • Increase in Investment in R&D

Roadblocks
  • Stringent Regulatory Factors

Opportunities
  • Increasing Advancement in The Treatment Techniques
  • Launch and addition of new therapies

Challenges
  • Lack of Awareness


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Shire Plc. (United States), Cook Group Incorporated (United States), Allergan plc (Ireland), Salix Pharmaceuticals Inc. (United States), novoGI, Inc. (United States), Novartis AG (Switzerland), Glaxosmithkline Inc. (United Kingdom), Pfizer Inc. (United States), Gilead Sciences, Inc. (United States) and Fresenius Kabi AG (Germany). Analyst at AMA Research see United States Players to retain maximum share of Global Diverticular Treatment market by 2026. Considering Market by Indication, the sub-segment i.e. Symptomatic Uncomplicated Diverticular Disease will boost the Diverticular Treatment market. Considering Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacy will boost the Diverticular Treatment market. Considering Market by Diagnosis, the sub-segment i.e. CT Scan will boost the Diverticular Treatment market.

Cook Group Incorporated is evaluating Hemospray device in phase 2 clinical trial to control colonic bleeding in severe diverticular disease., and Shire Plc. is evaluating SPD476 and SPD476 MMX in phase 3 clinical trial to reduce recurrence of diverticulitis.

What Can be Explored with the Diverticular Treatment Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Diverticular Treatment Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Diverticular Treatment
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Diverticular Treatment market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Diverticular Treatment market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Diverticular Treatment Provider, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Antibiotics Treatment
  • Symptomatic Treatment
By Application
  • Diverticulosis
  • Diverticulitis
By Indication
  • Symptomatic Uncomplicated Diverticular Disease
  • Recurrent Symptomatic Diverticular Disease
  • Complicated Diverticular Disease

By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacy
  • Others

By Diagnosis
  • CT Scan
  • Ultrasound
  • Urine Test
  • Blood Test

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence and Recurrence of Diverticular Disease
      • 3.2.2. Rise in Cigarette Smoking Population
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness
    • 3.4. Market Trends
      • 3.4.1. Increase in Investment in R&D
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Diverticular Treatment, by Type, Application, Indication, Distribution Channel, Diagnosis and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Diverticular Treatment (Value)
      • 5.2.1. Global Diverticular Treatment by: Type (Value)
        • 5.2.1.1. Antibiotics Treatment
        • 5.2.1.2. Symptomatic Treatment
      • 5.2.2. Global Diverticular Treatment by: Application (Value)
        • 5.2.2.1. Diverticulosis
        • 5.2.2.2. Diverticulitis
      • 5.2.3. Global Diverticular Treatment by: Indication (Value)
        • 5.2.3.1. Symptomatic Uncomplicated Diverticular Disease
        • 5.2.3.2. Recurrent Symptomatic Diverticular Disease
        • 5.2.3.3. Complicated Diverticular Disease
      • 5.2.4. Global Diverticular Treatment by: Distribution Channel (Value)
        • 5.2.4.1. Hospital Pharmacy
        • 5.2.4.2. Retail Pharmacies
        • 5.2.4.3. Drug Stores
        • 5.2.4.4. Online Pharmacy
        • 5.2.4.5. Others
      • 5.2.5. Global Diverticular Treatment by: Diagnosis (Value)
        • 5.2.5.1. CT Scan
        • 5.2.5.2. Ultrasound
        • 5.2.5.3. Urine Test
        • 5.2.5.4. Blood Test
      • 5.2.6. Global Diverticular Treatment Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Diverticular Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Shire Plc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cook Group Incorporated (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Allergan plc (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Salix Pharmaceuticals Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. NovoGI, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Novartis AG (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Glaxosmithkline Inc. (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Pfizer Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Gilead Sciences, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Fresenius Kabi AG (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Diverticular Treatment Sale, by Type, Application, Indication, Distribution Channel, Diagnosis and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Diverticular Treatment (Value)
      • 7.2.1. Global Diverticular Treatment by: Type (Value)
        • 7.2.1.1. Antibiotics Treatment
        • 7.2.1.2. Symptomatic Treatment
      • 7.2.2. Global Diverticular Treatment by: Application (Value)
        • 7.2.2.1. Diverticulosis
        • 7.2.2.2. Diverticulitis
      • 7.2.3. Global Diverticular Treatment by: Indication (Value)
        • 7.2.3.1. Symptomatic Uncomplicated Diverticular Disease
        • 7.2.3.2. Recurrent Symptomatic Diverticular Disease
        • 7.2.3.3. Complicated Diverticular Disease
      • 7.2.4. Global Diverticular Treatment by: Distribution Channel (Value)
        • 7.2.4.1. Hospital Pharmacy
        • 7.2.4.2. Retail Pharmacies
        • 7.2.4.3. Drug Stores
        • 7.2.4.4. Online Pharmacy
        • 7.2.4.5. Others
      • 7.2.5. Global Diverticular Treatment by: Diagnosis (Value)
        • 7.2.5.1. CT Scan
        • 7.2.5.2. Ultrasound
        • 7.2.5.3. Urine Test
        • 7.2.5.4. Blood Test
      • 7.2.6. Global Diverticular Treatment Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Diverticular Treatment: by Type(USD Million)
  • Table 2. Diverticular Treatment Antibiotics Treatment , by Region USD Million (2015-2020)
  • Table 3. Diverticular Treatment Symptomatic Treatment , by Region USD Million (2015-2020)
  • Table 4. Diverticular Treatment: by Application(USD Million)
  • Table 5. Diverticular Treatment Diverticulosis , by Region USD Million (2015-2020)
  • Table 6. Diverticular Treatment Diverticulitis , by Region USD Million (2015-2020)
  • Table 7. Diverticular Treatment: by Indication(USD Million)
  • Table 8. Diverticular Treatment Symptomatic Uncomplicated Diverticular Disease , by Region USD Million (2015-2020)
  • Table 9. Diverticular Treatment Recurrent Symptomatic Diverticular Disease , by Region USD Million (2015-2020)
  • Table 10. Diverticular Treatment Complicated Diverticular Disease , by Region USD Million (2015-2020)
  • Table 11. Diverticular Treatment: by Distribution Channel(USD Million)
  • Table 12. Diverticular Treatment Hospital Pharmacy , by Region USD Million (2015-2020)
  • Table 13. Diverticular Treatment Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 14. Diverticular Treatment Drug Stores , by Region USD Million (2015-2020)
  • Table 15. Diverticular Treatment Online Pharmacy , by Region USD Million (2015-2020)
  • Table 16. Diverticular Treatment Others , by Region USD Million (2015-2020)
  • Table 17. Diverticular Treatment: by Diagnosis(USD Million)
  • Table 18. Diverticular Treatment CT Scan , by Region USD Million (2015-2020)
  • Table 19. Diverticular Treatment Ultrasound , by Region USD Million (2015-2020)
  • Table 20. Diverticular Treatment Urine Test , by Region USD Million (2015-2020)
  • Table 21. Diverticular Treatment Blood Test , by Region USD Million (2015-2020)
  • Table 22. South America Diverticular Treatment, by Country USD Million (2015-2020)
  • Table 23. South America Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 24. South America Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 25. South America Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 26. South America Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 27. South America Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 28. Brazil Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 29. Brazil Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 30. Brazil Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 31. Brazil Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 32. Brazil Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 33. Argentina Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 34. Argentina Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 35. Argentina Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 36. Argentina Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 37. Argentina Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 38. Rest of South America Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 39. Rest of South America Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 40. Rest of South America Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 41. Rest of South America Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 42. Rest of South America Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 43. Asia Pacific Diverticular Treatment, by Country USD Million (2015-2020)
  • Table 44. Asia Pacific Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 45. Asia Pacific Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 46. Asia Pacific Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 47. Asia Pacific Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 48. Asia Pacific Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 49. China Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 50. China Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 51. China Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 52. China Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 53. China Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 54. Japan Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 55. Japan Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 56. Japan Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 57. Japan Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 58. Japan Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 59. India Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 60. India Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 61. India Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 62. India Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 63. India Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 64. South Korea Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 65. South Korea Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 66. South Korea Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 67. South Korea Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 68. South Korea Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 69. Taiwan Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 70. Taiwan Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 71. Taiwan Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 72. Taiwan Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 73. Taiwan Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 74. Australia Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 75. Australia Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 76. Australia Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 77. Australia Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 78. Australia Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 79. Rest of Asia-Pacific Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 80. Rest of Asia-Pacific Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 81. Rest of Asia-Pacific Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 82. Rest of Asia-Pacific Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 83. Rest of Asia-Pacific Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 84. Europe Diverticular Treatment, by Country USD Million (2015-2020)
  • Table 85. Europe Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 86. Europe Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 87. Europe Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 88. Europe Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 89. Europe Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 90. Germany Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 91. Germany Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 92. Germany Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 93. Germany Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 94. Germany Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 95. France Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 96. France Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 97. France Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 98. France Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 99. France Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 100. Italy Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 101. Italy Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 102. Italy Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 103. Italy Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 104. Italy Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 105. United Kingdom Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 106. United Kingdom Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 107. United Kingdom Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 108. United Kingdom Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 109. United Kingdom Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 110. Netherlands Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 111. Netherlands Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 112. Netherlands Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 113. Netherlands Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 114. Netherlands Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 115. Rest of Europe Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 116. Rest of Europe Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 117. Rest of Europe Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 118. Rest of Europe Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 119. Rest of Europe Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 120. MEA Diverticular Treatment, by Country USD Million (2015-2020)
  • Table 121. MEA Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 122. MEA Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 123. MEA Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 124. MEA Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 125. MEA Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 126. Middle East Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 127. Middle East Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 128. Middle East Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 129. Middle East Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 130. Middle East Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 131. Africa Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 132. Africa Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 133. Africa Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 134. Africa Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 135. Africa Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 136. North America Diverticular Treatment, by Country USD Million (2015-2020)
  • Table 137. North America Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 138. North America Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 139. North America Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 140. North America Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 141. North America Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 142. United States Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 143. United States Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 144. United States Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 145. United States Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 146. United States Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 147. Canada Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 148. Canada Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 149. Canada Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 150. Canada Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 151. Canada Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 152. Mexico Diverticular Treatment, by Type USD Million (2015-2020)
  • Table 153. Mexico Diverticular Treatment, by Application USD Million (2015-2020)
  • Table 154. Mexico Diverticular Treatment, by Indication USD Million (2015-2020)
  • Table 155. Mexico Diverticular Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 156. Mexico Diverticular Treatment, by Diagnosis USD Million (2015-2020)
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Diverticular Treatment: by Type(USD Million)
  • Table 168. Diverticular Treatment Antibiotics Treatment , by Region USD Million (2021-2026)
  • Table 169. Diverticular Treatment Symptomatic Treatment , by Region USD Million (2021-2026)
  • Table 170. Diverticular Treatment: by Application(USD Million)
  • Table 171. Diverticular Treatment Diverticulosis , by Region USD Million (2021-2026)
  • Table 172. Diverticular Treatment Diverticulitis , by Region USD Million (2021-2026)
  • Table 173. Diverticular Treatment: by Indication(USD Million)
  • Table 174. Diverticular Treatment Symptomatic Uncomplicated Diverticular Disease , by Region USD Million (2021-2026)
  • Table 175. Diverticular Treatment Recurrent Symptomatic Diverticular Disease , by Region USD Million (2021-2026)
  • Table 176. Diverticular Treatment Complicated Diverticular Disease , by Region USD Million (2021-2026)
  • Table 177. Diverticular Treatment: by Distribution Channel(USD Million)
  • Table 178. Diverticular Treatment Hospital Pharmacy , by Region USD Million (2021-2026)
  • Table 179. Diverticular Treatment Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 180. Diverticular Treatment Drug Stores , by Region USD Million (2021-2026)
  • Table 181. Diverticular Treatment Online Pharmacy , by Region USD Million (2021-2026)
  • Table 182. Diverticular Treatment Others , by Region USD Million (2021-2026)
  • Table 183. Diverticular Treatment: by Diagnosis(USD Million)
  • Table 184. Diverticular Treatment CT Scan , by Region USD Million (2021-2026)
  • Table 185. Diverticular Treatment Ultrasound , by Region USD Million (2021-2026)
  • Table 186. Diverticular Treatment Urine Test , by Region USD Million (2021-2026)
  • Table 187. Diverticular Treatment Blood Test , by Region USD Million (2021-2026)
  • Table 188. South America Diverticular Treatment, by Country USD Million (2021-2026)
  • Table 189. South America Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 190. South America Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 191. South America Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 192. South America Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 193. South America Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 194. Brazil Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 195. Brazil Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 196. Brazil Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 197. Brazil Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 198. Brazil Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 199. Argentina Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 200. Argentina Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 201. Argentina Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 202. Argentina Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 203. Argentina Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 204. Rest of South America Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 205. Rest of South America Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 206. Rest of South America Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 207. Rest of South America Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 208. Rest of South America Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 209. Asia Pacific Diverticular Treatment, by Country USD Million (2021-2026)
  • Table 210. Asia Pacific Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 211. Asia Pacific Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 212. Asia Pacific Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 213. Asia Pacific Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 214. Asia Pacific Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 215. China Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 216. China Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 217. China Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 218. China Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 219. China Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 220. Japan Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 221. Japan Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 222. Japan Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 223. Japan Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 224. Japan Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 225. India Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 226. India Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 227. India Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 228. India Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 229. India Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 230. South Korea Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 231. South Korea Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 232. South Korea Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 233. South Korea Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 234. South Korea Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 235. Taiwan Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 236. Taiwan Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 237. Taiwan Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 238. Taiwan Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 239. Taiwan Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 240. Australia Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 241. Australia Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 242. Australia Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 243. Australia Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 244. Australia Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 245. Rest of Asia-Pacific Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 246. Rest of Asia-Pacific Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 247. Rest of Asia-Pacific Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 248. Rest of Asia-Pacific Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 249. Rest of Asia-Pacific Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 250. Europe Diverticular Treatment, by Country USD Million (2021-2026)
  • Table 251. Europe Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 252. Europe Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 253. Europe Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 254. Europe Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 255. Europe Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 256. Germany Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 257. Germany Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 258. Germany Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 259. Germany Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 260. Germany Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 261. France Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 262. France Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 263. France Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 264. France Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 265. France Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 266. Italy Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 267. Italy Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 268. Italy Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 269. Italy Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 270. Italy Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 271. United Kingdom Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 272. United Kingdom Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 273. United Kingdom Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 274. United Kingdom Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 275. United Kingdom Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 276. Netherlands Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 277. Netherlands Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 278. Netherlands Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 279. Netherlands Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 280. Netherlands Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 281. Rest of Europe Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 282. Rest of Europe Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 283. Rest of Europe Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 284. Rest of Europe Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 285. Rest of Europe Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 286. MEA Diverticular Treatment, by Country USD Million (2021-2026)
  • Table 287. MEA Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 288. MEA Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 289. MEA Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 290. MEA Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 291. MEA Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 292. Middle East Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 293. Middle East Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 294. Middle East Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 295. Middle East Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 296. Middle East Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 297. Africa Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 298. Africa Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 299. Africa Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 300. Africa Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 301. Africa Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 302. North America Diverticular Treatment, by Country USD Million (2021-2026)
  • Table 303. North America Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 304. North America Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 305. North America Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 306. North America Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 307. North America Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 308. United States Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 309. United States Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 310. United States Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 311. United States Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 312. United States Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 313. Canada Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 314. Canada Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 315. Canada Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 316. Canada Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 317. Canada Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 318. Mexico Diverticular Treatment, by Type USD Million (2021-2026)
  • Table 319. Mexico Diverticular Treatment, by Application USD Million (2021-2026)
  • Table 320. Mexico Diverticular Treatment, by Indication USD Million (2021-2026)
  • Table 321. Mexico Diverticular Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 322. Mexico Diverticular Treatment, by Diagnosis USD Million (2021-2026)
  • Table 323. Research Programs/Design for This Report
  • Table 324. Key Data Information from Secondary Sources
  • Table 325. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Diverticular Treatment: by Type USD Million (2015-2020)
  • Figure 5. Global Diverticular Treatment: by Application USD Million (2015-2020)
  • Figure 6. Global Diverticular Treatment: by Indication USD Million (2015-2020)
  • Figure 7. Global Diverticular Treatment: by Distribution Channel USD Million (2015-2020)
  • Figure 8. Global Diverticular Treatment: by Diagnosis USD Million (2015-2020)
  • Figure 9. South America Diverticular Treatment Share (%), by Country
  • Figure 10. Asia Pacific Diverticular Treatment Share (%), by Country
  • Figure 11. Europe Diverticular Treatment Share (%), by Country
  • Figure 12. MEA Diverticular Treatment Share (%), by Country
  • Figure 13. North America Diverticular Treatment Share (%), by Country
  • Figure 14. Global Diverticular Treatment share by Players 2020 (%)
  • Figure 15. Global Diverticular Treatment share by Players (Top 3) 2020(%)
  • Figure 16. Global Diverticular Treatment share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Shire Plc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Shire Plc. (United States) Revenue: by Geography 2020
  • Figure 20. Cook Group Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 21. Cook Group Incorporated (United States) Revenue: by Geography 2020
  • Figure 22. Allergan plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 23. Allergan plc (Ireland) Revenue: by Geography 2020
  • Figure 24. Salix Pharmaceuticals Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Salix Pharmaceuticals Inc. (United States) Revenue: by Geography 2020
  • Figure 26. NovoGI, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. NovoGI, Inc. (United States) Revenue: by Geography 2020
  • Figure 28. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 29. Novartis AG (Switzerland) Revenue: by Geography 2020
  • Figure 30. Glaxosmithkline Inc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 31. Glaxosmithkline Inc. (United Kingdom) Revenue: by Geography 2020
  • Figure 32. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 34. Gilead Sciences, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Gilead Sciences, Inc. (United States) Revenue: by Geography 2020
  • Figure 36. Fresenius Kabi AG (Germany) Revenue, Net Income and Gross profit
  • Figure 37. Fresenius Kabi AG (Germany) Revenue: by Geography 2020
  • Figure 38. Global Diverticular Treatment: by Type USD Million (2021-2026)
  • Figure 39. Global Diverticular Treatment: by Application USD Million (2021-2026)
  • Figure 40. Global Diverticular Treatment: by Indication USD Million (2021-2026)
  • Figure 41. Global Diverticular Treatment: by Distribution Channel USD Million (2021-2026)
  • Figure 42. Global Diverticular Treatment: by Diagnosis USD Million (2021-2026)
  • Figure 43. South America Diverticular Treatment Share (%), by Country
  • Figure 44. Asia Pacific Diverticular Treatment Share (%), by Country
  • Figure 45. Europe Diverticular Treatment Share (%), by Country
  • Figure 46. MEA Diverticular Treatment Share (%), by Country
  • Figure 47. North America Diverticular Treatment Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Shire Plc. (United States)
  • Cook Group Incorporated (United States)
  • Allergan plc (Ireland)
  • Salix Pharmaceuticals Inc. (United States)
  • novoGI, Inc. (United States)
  • Novartis AG (Switzerland)
  • Glaxosmithkline Inc. (United Kingdom)
  • Pfizer Inc. (United States)
  • Gilead Sciences, Inc. (United States)
  • Fresenius Kabi AG (Germany)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation